Showing posts with label BAC. Show all posts
Showing posts with label BAC. Show all posts

April 1, 2022

Notable Analyst Upgrades and Downgrades for Week of March 28 2022

 



Upgrades:

 


Bank of America (NYSE:BAC) was upgraded by research analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating in a report issued on Monday, The Fly reports.

Several other research firms also recently issued reports on BAC. JPMorgan Chase & Co. lifted their price target on Bank of America from $52.50 to $53.50 in a research note on Thursday, February 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Bank of America in a research note on Friday, December 17th. Argus boosted their target price on shares of Bank of America from $50.00 to $55.00 in a research note on Thursday, January 20th. Societe Generale downgraded shares of Bank of America from a "buy" rating to a "hold" rating in a research note on Wednesday, January 5th. They noted that the move was a valuation call. Finally, Robert W. Baird raised shares of Bank of America from an "underperform" rating to a "neutral" rating and set a $42.00 target price for the company in a research note on Tuesday, March 8th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $50.38. Read more …

 


Deere & Company (NYSE:DE) was upgraded by investment analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating in a report released on Monday, The Fly reports. The firm presently has a $440.00 target price on the industrial products company's stock, up from their previous target price of $355.00. JPMorgan Chase & Co.'s target price would suggest a potential upside of 0.81% from the company's previous close.

A number of other analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Deere & Company from $400.00 to $417.00 and gave the company a "hold" rating in a research note on Tuesday, February 22nd. Evercore ISI upped their price objective on shares of Deere & Company from $354.00 to $415.00 in a research note on Monday, November 29th. Jefferies Financial Group reaffirmed a "buy" rating and set a $450.00 price objective on shares of Deere & Company in a research note on Friday, December 3rd. Zacks Investment Research lowered shares of Deere & Company from a "buy" rating to a "hold" rating and set a $412.00 price objective for the company. in a research note on Monday, February 14th. Finally, Wells Fargo & Company began coverage on shares of Deere & Company in a research report on Friday, March 11th. They issued an "overweight" rating and a $455.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Deere & Company currently has an average rating of "Buy" and an average price target of $437.59. Read more …

 


Illinois Tool Works (NYSE:ITW) was upgraded by equities researchers at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research report issued to clients and investors on Monday, The Fly reports. The firm currently has a $255.00 price objective on the industrial products company's stock, down from their prior price objective of $262.00. JPMorgan Chase & Co.'s price objective suggests a potential upside of 20.43% from the stock's previous close.

Other equities analysts also recently issued research reports about the company. Morgan Stanley cut their price target on Illinois Tool Works from $218.00 to $210.00 and set an "underweight" rating for the company in a research note on Monday, February 7th. The Goldman Sachs Group lifted their target price on shares of Illinois Tool Works from $239.00 to $263.00 and gave the stock a "neutral" rating in a research report on Monday, December 13th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Illinois Tool Works from $231.00 to $220.00 and set a "hold" rating on the stock in a research report on Friday, December 10th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $239.54. Read more …

 

 

 

Downgrades:

 


Citigroup (NYSE:C) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating in a research report issued on Monday, The Fly reports. They currently have a $60.00 price objective on the stock, down from their prior price objective of $75.00. Morgan Stanley’s target price would suggest a potential upside of 5.75% from the company’s previous close.

Several other research analysts also recently commented on C. BMO Capital Markets decreased their price objective on Citigroup from $83.00 to $78.00 and set a “buy” rating on the stock in a report on Thursday, March 3rd. Jefferies Financial Group downgraded Citigroup from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $79.00 to $60.00 in a report on Monday, March 7th. Piper Sandler reduced their price target on Citigroup from $88.00 to $85.00 in a report on Tuesday, January 18th. Credit Suisse Group reduced their price target on Citigroup from $72.00 to $66.00 and set an “outperform” rating on the stock in a report on Monday, March 7th. Finally, Oppenheimer reduced their price target on Citigroup from $120.00 to $114.00 in a report on Tuesday, January 18th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $74.75. Read more …

 


Campbell Soup (NYSE:CPB) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a report released on Monday, The Fly reports. They presently have a $46.00 price target on the stock, down from their previous price target of $47.00. Royal Bank of Canada’s price objective suggests a potential upside of 3.30% from the stock’s previous close.

A number of other brokerages have also issued reports on CPB. Credit Suisse Group raised their target price on shares of Campbell Soup from $41.00 to $43.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 14th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Campbell Soup from $45.00 to $46.00 in a research report on Tuesday, March 1st. Citigroup raised their target price on shares of Campbell Soup from $45.00 to $46.00 and gave the stock a “neutral” rating in a research report on Thursday, March 10th. Evercore ISI restated a “hold” rating on shares of Campbell Soup in a research report on Thursday, December 16th. Finally, StockNews.com lowered shares of Campbell Soup from a “buy” rating to a “hold” rating in a research report on Friday, February 25th. One investment analyst has rated the stock with a sell rating and ten have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $44.56. Read more …

 


Altria Group (NYSE:MO) was downgraded by equities researchers at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating in a report issued on Monday, The Fly reports.

Several other research firms also recently issued reports on MO. Morgan Stanley boosted their price objective on shares of Altria Group from $47.00 to $51.00 and gave the stock an "equal weight" rating in a research note on Wednesday, January 26th. Bank of America downgraded shares of Altria Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $56.00 to $50.00 in a research note on Wednesday, January 5th. Finally, The Goldman Sachs Group raised shares of Altria Group from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $48.00 to $57.00 in a research report on Tuesday, March 22nd. Five analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $54.17.

Shares of MO opened at $53.62 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.57 and a debt-to-equity ratio of 8.67. The stock has a market cap of $97.44 billion, a P/E ratio of 40.32, a PEG ratio of 2.77 and a beta of 0.59. The company has a 50-day moving average of $51.17 and a two-hundred day moving average of $48.29. Altria Group has a 12-month low of $42.53 and a 12-month high of $53.96. Read more …

 

 


CVS Health (NYSE:CVS) was downgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating in a research note issued to investors on Tuesday, Briefing.com reports. They presently have a $110.00 price objective on the pharmacy operator's stock. Deutsche Bank Aktiengesellschaft's price target points to a potential upside of 1.81% from the company's previous close.

Other equities analysts have also issued research reports about the company. Truist Financial upped their price target on CVS Health from $118.00 to $124.00 and gave the company a "buy" rating in a research note on Wednesday, January 5th. Wells Fargo & Company upped their price objective on CVS Health from $98.00 to $107.00 and gave the company an "equal weight" rating in a report on Monday, December 13th. The Goldman Sachs Group started coverage on CVS Health in a report on Tuesday, December 14th. They issued a "buy" rating and a $121.00 price objective for the company. Tigress Financial upped their price objective on CVS Health from $108.00 to $122.00 and gave the company a "buy" rating in a report on Thursday, December 23rd. Finally, Seaport Global Securities initiated coverage on CVS Health in a report on Wednesday, December 1st. They issued a "buy" rating and a $110.00 price target for the company. Four analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $112.95. Read more …

 


Bank of New York Mellon (NYSE:BK) was downgraded by equities research analysts at The Goldman Sachs Group from a "buy" rating to a "neutral" rating in a research note issued on Wednesday, The Fly reports.

Several other analysts also recently issued reports on the company. Wells Fargo & Company decreased their price target on Bank of New York Mellon from $70.00 to $63.00 and set an "equal weight" rating for the company in a research note on Tuesday, March 22nd. Keefe, Bruyette & Woods downgraded Bank of New York Mellon from an "outperform" rating to a "market perform" rating and increased their target price for the company from $66.00 to $70.00 in a research note on Tuesday, January 11th. Zacks Investment Research upgraded Bank of New York Mellon from a "hold" rating to a "buy" rating and set a $66.00 target price for the company in a research note on Monday, January 10th. Barclays increased their target price on Bank of New York Mellon from $62.00 to $74.00 in a research note on Monday, January 3rd. Finally, JPMorgan Chase & Co. upgraded Bank of New York Mellon from a "neutral" rating to an "overweight" rating and increased their target price for the company from $62.50 to $67.00 in a research note on Thursday, December 16th. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $63.57. Read more …

 


Kimco Realty (NYSE:KIM) was downgraded by investment analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a report released on Wednesday, The Fly reports.

Other equities research analysts also recently issued reports about the company. Jefferies Financial Group raised Kimco Realty from a "hold" rating to a "buy" rating and increased their price target for the stock from $24.00 to $29.00 in a research report on Monday, January 10th. StockNews.com raised Kimco Realty from a "sell" rating to a "hold" rating in a research report on Tuesday, February 22nd. Citigroup increased their price target on Kimco Realty from $26.00 to $28.00 and gave the stock a "buy" rating in a research report on Thursday, December 2nd. Deutsche Bank Aktiengesellschaft downgraded Kimco Realty from a "buy" rating to a "hold" rating and increased their price target for the stock from $24.00 to $26.00 in a research report on Monday, January 3rd. Finally, Truist Financial raised their target price on Kimco Realty from $25.00 to $27.00 and gave the company a "buy" rating in a research report on Friday, December 10th. Six equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $26.07. Read more …

 

 


Procter & Gamble (NYSE:PG) was downgraded by equities research analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a report issued on Wednesday, The Fly reports.

Several other brokerages also recently weighed in on PG. StockNews.com raised Procter & Gamble from a "hold" rating to a "buy" rating in a research report on Wednesday. Truist Financial upgraded Procter & Gamble from a "hold" rating to a "buy" rating and raised their target price for the company from $165.00 to $175.00 in a research report on Tuesday, March 22nd. Zacks Investment Research cut Procter & Gamble from a "hold" rating to a "sell" rating and set a $163.00 target price on the stock. in a research report on Tuesday. Royal Bank of Canada raised their target price on Procter & Gamble from $150.00 to $160.00 and gave the company a "sector perform" rating in a research report on Thursday, January 20th. Finally, The Goldman Sachs Group dropped their target price on Procter & Gamble from $179.00 to $173.00 in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $158.85. Read more …

 


HP (NYSE:HPQ) was downgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating in a note issued to investors on Thursday, Marketbeat Ratings reports. They presently have a $31.00 price objective on the computer maker’s stock, down from their prior price objective of $34.00. Morgan Stanley’s target price indicates a potential downside of 20.19% from the company’s previous close.

Several other analysts also recently commented on HPQ. Barclays increased their target price on shares of HP from $29.00 to $30.00 and gave the company an “underweight” rating in a report on Tuesday, March 1st. JPMorgan Chase & Co. increased their target price on shares of HP from $38.00 to $40.00 in a research report on Thursday, January 20th. StockNews.com started coverage on shares of HP in a research report on Thursday. They set a “buy” rating for the company. Sanford C. Bernstein increased their target price on shares of HP from $32.00 to $40.00 in a research report on Tuesday, January 11th. Finally, Evercore ISI reiterated a “buy” rating and set a $42.00 target price on shares of HP in a research report on Friday, February 25th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, HP currently has an average rating of “Hold” and an average price target of $35.79. Read more …

 


Canadian Utilities (TSE:CU) was downgraded by TD Securities from a “buy” rating to a “hold” rating in a research note issued on Friday, BayStreet.CA reports. They currently have a C$39.00 price objective on the stock. TD Securities’ price objective would suggest a potential upside of 2.20% from the company’s current price.

Separately, National Bankshares decreased their price objective on shares of Canadian Utilities from C$37.00 to C$36.00 in a research report on Wednesday, January 26th. Eight investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Canadian Utilities currently has a consensus rating of “Hold” and an average price target of C$37.11.

Shares of TSE CU traded down C$0.16 during trading on Friday, hitting C$38.16. 177,970 shares of the company were exchanged, compared to its average volume of 643,627. The company has a market cap of C$10.28 billion and a price-to-earnings ratio of 31.54. Canadian Utilities has a 1 year low of C$33.76 and a 1 year high of C$38.51. The firm’s fifty day moving average price is C$36.17 and its 200 day moving average price is C$35.59. The company has a debt-to-equity ratio of 140.27, a current ratio of 1.22 and a quick ratio of 1.10. Read more …

 

 


Walgreens Boots Alliance (NASDAQ:WBA) was downgraded by Robert W. Baird from an “outperform” rating to a “neutral” rating in a research report issued to clients and investors on Friday, The Fly reports. They presently have a $51.00 price objective on the pharmacy operator’s stock, down from their prior price objective of $70.00. Robert W. Baird’s price target indicates a potential upside of 13.92% from the company’s previous close.

WBA has been the topic of several other research reports. StockNews.com started coverage on Walgreens Boots Alliance in a research report on Thursday. They set a “buy” rating on the stock. Morgan Stanley downgraded Walgreens Boots Alliance from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $56.00 to $49.00 in a research note on Thursday, December 16th. Mizuho raised their price target on Walgreens Boots Alliance from $51.00 to $56.00 in a research note on Monday, January 10th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $56.00 price target on the stock in a research note on Tuesday, January 4th. Finally, TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b-” rating in a research note on Monday, January 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $52.33. Read more …

 

March 11, 2022

Notable Analyst Upgrades and Downgrades for Week of March 7 2022 (Part 1)

 



Upgrades:

 


NextEra Energy (NYSE:NEE) was upgraded by research analysts at KeyCorp to an "overweight" rating in a research report issued on Monday, Stock Target Advisor reports. The firm presently has a $87.00 target price on the utilities provider's stock. KeyCorp's price target would suggest a potential upside of 8.47% from the stock's previous close.

Several other equities analysts have also recently issued reports on NEE. BMO Capital Markets boosted their price objective on NextEra Energy from $89.00 to $98.00 and gave the company an "outperform" rating in a report on Wednesday, December 8th. Morgan Stanley lowered their price objective on NextEra Energy from $90.00 to $88.00 and set an "equal weight" rating on the stock in a research report on Friday, February 18th. Mizuho dropped their price objective on shares of NextEra Energy from $91.00 to $88.00 in a research note on Monday, January 24th. Finally, Wells Fargo & Company decreased their target price on shares of NextEra Energy from $104.00 to $102.00 and set an "overweight" rating for the company in a research note on Wednesday, January 26th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $89.43. Read more …

 


Bank of America (NYSE:BAC) was upgraded by research analysts at Robert W. Baird from an "underperform" rating to a "neutral" rating in a research report issued on Tuesday, Briefing.com reports. The firm presently has a $42.00 price objective on the financial services provider's stock. Robert W. Baird's price objective would indicate a potential upside of 9.55% from the company's current price.

A number of other analysts have also recently commented on BAC. Societe Generale downgraded Bank of America from a "buy" rating to a "hold" rating in a report on Wednesday, January 5th. They noted that the move was a valuation call. UBS Group assumed coverage on Bank of America in a report on Friday, December 10th. They set a "buy" rating and a $64.00 price target for the company. Zacks Investment Research downgraded Bank of America from a "buy" rating to a "hold" rating and set a $51.00 price objective on the stock. in a research note on Monday, February 7th. Morgan Stanley raised their target price on shares of Bank of America from $49.00 to $51.00 and gave the stock an "underweight" rating in a research note on Thursday, January 20th. Finally, Argus raised their price objective on shares of Bank of America from $50.00 to $55.00 in a research report on Thursday, January 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and an average price target of $50.38. Read more …

 


Caterpillar (NYSE:CAT) was upgraded by Jefferies Financial Group from a "hold" rating to a "buy" rating in a report issued on Tuesday, Benzinga reports. The brokerage currently has a $260.00 price objective on the industrial products company's stock, up from their previous price objective of $215.00. Jefferies Financial Group's target price would suggest a potential upside of 32.18% from the stock's current price.

Several other brokerages also recently commented on CAT. Morgan Stanley cut their price target on shares of Caterpillar from $166.00 to $164.00 and set an "underweight" rating on the stock in a report on Thursday, December 9th. StockNews.com downgraded shares of Caterpillar from a "buy" rating to a "hold" rating in a research note on Saturday, February 5th. Credit Suisse Group dropped their price objective on shares of Caterpillar from $275.00 to $255.00 and set an "outperform" rating on the stock in a research note on Monday, January 31st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Caterpillar from $233.00 to $242.00 and gave the company a "buy" rating in a research note on Friday, December 10th. Finally, Citigroup increased their price objective on shares of Caterpillar from $225.00 to $230.00 in a research note on Thursday, January 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $242.18. Read more …

 

 


Fastenal (NASDAQ:FAST) was upgraded by equities researchers at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating in a note issued to investors on Tuesday, Briefing.com reports. The brokerage presently has a $58.00 target price on the stock, up from their previous target price of $50.00. Wells Fargo & Company's target price would indicate a potential upside of 7.21% from the company's previous close.

Several other equities research analysts have also commented on FAST. Loop Capital upped their target price on Fastenal from $53.00 to $57.00 and gave the company a "hold" rating in a research report on Tuesday, December 7th. They noted that the move was a valuation call. StockNews.com lowered Fastenal from a "buy" rating to a "hold" rating in a research report on Thursday, March 3rd. Robert W. Baird upped their target price on Fastenal from $64.00 to $66.00 in a research report on Monday. Finally, Morgan Stanley upped their target price on Fastenal from $53.00 to $54.00 and gave the company an "underweight" rating in a research report on Thursday, January 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $59.50. Read more …

January 7, 2022

Notable Analyst Upgrades and Downgrades for Week of January 3 2022 (Part 2)



 

Upgrades:

 


Kimco Realty (NYSE:KIM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating in a research report issued on Wednesday, Analyst Ratings Network reports. The brokerage currently has a $27.00 target price on the real estate investment trust's stock. Argus' price objective indicates a potential upside of 7.02% from the stock's previous close.

KIM has been the topic of a number of other research reports. Evercore ISI upgraded Kimco Realty from an "in-line" rating to an "outperform" rating and lifted their target price for the company from $24.00 to $26.00 in a research report on Monday, November 22nd. Wolfe Research initiated coverage on Kimco Realty in a research report on Thursday, September 23rd. They issued a "market perform" rating and a $24.00 target price on the stock. Citigroup lifted their target price on Kimco Realty from $26.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, December 2nd. Truist lifted their target price on Kimco Realty from $25.00 to $27.00 and gave the company a "buy" rating in a research report on Friday, December 10th. Finally, Deutsche Bank Aktiengesellschaft downgraded Kimco Realty from a "buy" rating to a "hold" rating and boosted their price objective for the company from $24.00 to $26.00 in a report on Monday. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $25.60. Read more …

 


MetLife (NYSE:MET) was upgraded by Evercore ISI from an "in-line" rating to an "outperform" rating in a report issued on Wednesday, Price Targets.com reports. The brokerage presently has a $75.00 price objective on the financial services provider's stock, up from their previous price objective of $67.00. Evercore ISI's price objective suggests a potential upside of 15.49% from the company's current price.

Several other research analysts also recently weighed in on MET. The Goldman Sachs Group assumed coverage on shares of MetLife in a research report on Thursday, December 2nd. They issued a "buy" rating and a $77.00 target price on the stock. Wells Fargo & Company dropped their target price on shares of MetLife from $75.00 to $74.00 and set an "overweight" rating on the stock in a research report on Tuesday. Barclays boosted their price objective on shares of MetLife from $69.00 to $72.00 and gave the company an "overweight" rating in a research report on Tuesday, October 12th. Finally, Morgan Stanley boosted their price objective on shares of MetLife from $74.00 to $75.00 and gave the company an "overweight" rating in a research report on Thursday, October 14th. Thirteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, MetLife has an average rating of "Buy" and an average price target of $69.29. Read more …

 


Pfizer (NYSE:PFE) was upgraded by Bank of America from a "neutral" rating to a "buy" rating in a report released on Wednesday, The Fly reports.

Several other research firms have also weighed in on PFE. Sanford C. Bernstein raised their price objective on shares of Pfizer from $44.00 to $65.00 and gave the company a "market perform" rating in a research report on Monday. UBS Group upgraded shares of Pfizer from a "neutral" rating to a "buy" rating and raised their target price for the stock from $52.00 to $60.00 in a report on Monday, December 13th. Truist raised their target price on shares of Pfizer from $43.00 to $58.00 and gave the stock a "buy" rating in a report on Wednesday, November 24th. JPMorgan Chase & Co. set a $53.00 target price on shares of Pfizer in a report on Monday, December 13th. Finally, Barclays set a $54.00 target price on shares of Pfizer in a report on Tuesday. Nine analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $56.15. Read more …

 

 


Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by equities research analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a report released on Wednesday, The Fly reports.

A number of other analysts have also recently commented on SU. Credit Suisse Group upped their price objective on shares of Suncor Energy from C$36.00 to C$42.00 and gave the company an "outperform" rating in a research report on Tuesday, November 2nd. BMO Capital Markets upped their price objective on shares of Suncor Energy from C$39.00 to C$43.00 and gave the company an "outperform" rating in a research report on Friday, October 29th. TD Securities increased their target price on Suncor Energy from C$39.00 to C$40.00 and gave the stock a "buy" rating in a report on Thursday, October 28th. Scotiabank increased their target price on Suncor Energy from C$33.00 to C$37.00 and gave the stock an "outperform" rating in a report on Friday, November 19th. Finally, JPMorgan Chase & Co. upgraded Suncor Energy from a "neutral" rating to an "overweight" rating and increased their target price for the stock from $29.00 to $39.00 in a report on Thursday, October 28th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $37.86. Read more …

November 5, 2021

Notable Analyst Upgrades and Downgrades for Week of November 1 2021 (Part 1)

 



Upgrades:

 


Intel (NASDAQ:INTC) was upgraded by analysts at Northland Securities from an “underperform” rating to a “market perform” rating in a research note issued on Monday, PriceTargets.com reports. The firm presently has a $49.00 price target on the chip maker’s stock. Northland Securities’ price target indicates a potential downside of 0.39% from the company’s current price.

A number of other equities research analysts also recently commented on INTC. The Goldman Sachs Group restated a “sell” rating and issued a $44.00 target price (down previously from $51.00) on shares of Intel in a research report on Friday, October 22nd. Zacks Investment Research upgraded Intel from a “hold” rating to a “buy” rating and set a $58.00 target price on the stock in a research report on Friday, July 9th. Citigroup reduced their target price on Intel from $57.00 to $52.00 and set a “neutral” rating on the stock in a research report on Friday, October 22nd. Credit Suisse Group set a $80.00 price objective on Intel in a report on Friday, October 22nd. Finally, Bank of America cut their price objective on Intel from $52.00 to $45.00 and set an “underperform” rating on the stock in a report on Friday, October 22nd. Eleven equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $56.52. Read more …

 


Merck & Co., Inc. (NYSE:MRK) was upgraded by equities researchers at Argus from a “hold” rating to a “buy” rating in a note issued to investors on Monday, Analyst Price Targets reports. The brokerage presently has a $110.00 price objective on the stock. Argus’ price objective would suggest a potential upside of 25.40% from the company’s previous close.

Other equities analysts have also recently issued reports about the company. Morgan Stanley lifted their price objective on Merck & Co., Inc. from $88.00 to $90.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays lifted their price objective on Merck & Co., Inc. from $87.00 to $92.00 and gave the stock an “overweight” rating in a report on Friday, October 8th. Truist began coverage on Merck & Co., Inc. in a research report on Tuesday, July 27th. They set a “buy” rating and a $92.00 price target for the company. Berenberg Bank reissued a “hold” rating and set a $92.00 price target (up previously from $86.00) on shares of Merck & Co., Inc. in a research report on Sunday, October 10th. Finally, Zacks Investment Research raised Merck & Co., Inc. from a “sell” rating to a “hold” rating and set a $82.00 price target for the company in a research report on Tuesday, August 24th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Merck & Co., Inc. presently has an average rating of “Buy” and an average target price of $94.16. Read more …

 


Starbucks (NASDAQ:SBUX) was upgraded by research analysts at Stephens from an “equal weight” rating to an “overweight” rating in a research note issued to investors on Monday, The Fly reports. The firm currently has a $130.00 price objective on the coffee company’s stock, up from their previous price objective of $118.00. Stephens’ price objective indicates a potential upside of 22.56% from the stock’s previous close.

A number of other equities research analysts have also weighed in on the stock. Piper Sandler boosted their price objective on shares of Starbucks from $104.00 to $108.00 and gave the stock a “neutral” rating in a report on Wednesday, July 28th. Bank of America assumed coverage on shares of Starbucks in a report on Monday, October 11th. They issued a “buy” rating and a $135.00 price objective for the company. Robert W. Baird lowered their price objective on shares of Starbucks from $144.00 to $128.00 and set an “outperform” rating for the company in a report on Friday. UBS Group lowered their price objective on shares of Starbucks from $125.00 to $115.00 and set a “neutral” rating for the company in a report on Friday. Finally, Atlantic Securities downgraded shares of Starbucks from an “overweight” rating to a “neutral” rating and set a $105.00 target price on the stock. in a research note on Thursday, September 30th. Nine analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $123.00. Read more …

 

 


Sanofi (NASDAQ:SNY) was upgraded by stock analysts at HSBC from a “hold” rating to a “buy” rating in a report released on Monday, The Fly reports.

Several other brokerages have also issued reports on SNY. UBS Group reiterated a “buy” rating on shares of Sanofi in a research note on Thursday, August 12th. Morgan Stanley restated an “overweight” rating on shares of Sanofi in a research note on Friday, August 6th. Zacks Investment Research upgraded shares of Sanofi from a “hold” rating to a “buy” rating and set a $51.00 price objective on the stock in a research note on Wednesday, September 29th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Sanofi in a research note on Thursday, October 14th. Finally, SVB Leerink upgraded shares of Sanofi from a “market perform” rating to an “outperform” rating in a research note on Monday, September 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $51.00. Read more …

October 17, 2021

Notable Analyst Upgrades and Downgrades for Week of October 11, 2021



 

Upgrades:

 



C.H. Robinson Worldwide (NASDAQ:CHRW)
 was upgraded by equities researchers at Vertical Research from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Monday, PriceTargets.com reports.

A number of other research firms also recently issued reports on CHRW. Evercore ISI began coverage on shares of C.H. Robinson Worldwide in a research note on Monday, September 13th. They issued an "inline" rating and a $95.00 price target for the company. Morgan Stanley increased their price target on shares of C.H. Robinson Worldwide from $58.00 to $60.00 and gave the stock an "underweight" rating in a research note on Thursday, July 8th. Wells Fargo & Company decreased their price target on shares of C.H. Robinson Worldwide from $95.00 to $90.00 and set an "underweight" rating for the company in a research note on Tuesday, July 13th. Zacks Investment Research downgraded shares of C.H. Robinson Worldwide from a "buy" rating to a "hold" rating and set a $94.00 price target for the company. in a research note on Monday, August 2nd. Finally, Citigroup decreased their price target on shares of C.H. Robinson Worldwide from $118.00 to $115.00 and set a "buy" rating for the company in a research note on Wednesday, July 14th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $98.31. Read more …

 



Eli Lilly and (NYSE:LLY)
 was upgraded by stock analysts at Berenberg Bank from a "hold" rating to a "buy" rating in a research note issued to investors on Monday, The Fly reports.

A number of other equities research analysts have also recently commented on LLY. Truist assumed coverage on Eli Lilly and in a research note on Tuesday, July 27th. They set a "buy" rating and a $262.00 target price on the stock. DZ Bank upgraded Eli Lilly and from a "hold" rating to a "buy" rating and set a $288.00 price objective on the stock in a research note on Thursday, August 5th. Mizuho boosted their price objective on Eli Lilly and from $250.00 to $279.00 and gave the company a "buy" rating in a research note on Wednesday, August 4th. Truist Securities upped their price target on Eli Lilly and from $225.00 to $262.00 and gave the company a "buy" rating in a research report on Friday, July 2nd. Finally, The Goldman Sachs Group upped their price target on Eli Lilly and from $252.00 to $270.00 and gave the company a "conviction-buy" rating in a research report on Monday, June 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Eli Lilly and presently has a consensus rating of "Buy" and a consensus target price of $257.53. Read more …

 


3M (NYSE:MMM)
 was upgraded by stock analysts at Langenberg & Company from a “hold” rating to a “buy” rating in a research report issued on Monday, The Fly reports.

Several other equities analysts also recently weighed in on MMM. Wolfe Research downgraded 3M from a “peer perform” rating to an “underperform” rating and dropped their price objective for the company from $218.00 to $215.00 in a research note on Monday, July 12th. Credit Suisse Group downgraded 3M from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $210.00 to $212.00 in a research note on Tuesday, July 6th. Zacks Investment Research raised 3M from a “hold” rating to a “buy” rating and set a $208.00 price objective for the company in a research note on Friday, August 6th. JPMorgan Chase & Co. downgraded 3M from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $215.00 to $210.00 in a research report on Monday, October 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on 3M from $196.00 to $201.00 and gave the stock a “hold” rating in a research report on Wednesday, July 28th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $196.54. Read more …

 

 


Starbucks (NASDAQ:SBUX)
 was upgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note issued on Monday, The Fly reports.

A number of other research firms also recently issued reports on SBUX. Barclays raised their price target on shares of Starbucks from $140.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 28th. Wells Fargo & Company assumed coverage on shares of Starbucks in a research report on Sunday, June 20th. They issued a “buy” rating on the stock. Cowen lifted their price objective on shares of Starbucks from $126.00 to $135.00 and gave the company an “outperform” rating in a research report on Wednesday, July 28th. BMO Capital Markets lifted their price objective on shares of Starbucks from $125.00 to $140.00 and gave the company an “outperform” rating in a research report on Wednesday, July 28th. Finally, Jefferies Financial Group lifted their price objective on shares of Starbucks from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Wednesday, July 28th. Eight equities research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $126.96. Read more …

 

October 9, 2021

Notable Analyst Upgrades and Downgrades for Week of October 4, 2021



 

Upgrades:

 


DuPont de Nemours (NYSE:DD) was upgraded by investment analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a report released on Monday, PriceTargets.com reports. The firm currently has a $85.00 price target on the basic materials company's stock, up from their previous price target of $84.00. JPMorgan Chase & Co.'s price objective suggests a potential upside of 22.96% from the stock's current price. The analysts noted that the move was a valuation call.

Several other research firms have also issued reports on DD. Citigroup increased their price target on shares of DuPont de Nemours from $96.00 to $102.00 and gave the stock a "buy" rating in a research report on Wednesday, August 4th. Wells Fargo & Company increased their price target on shares of DuPont de Nemours from $95.00 to $97.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 13th. Zacks Investment Research lowered shares of DuPont de Nemours from a "strong-buy" rating to a "hold" rating and set a $83.00 price target on the stock. in a research report on Thursday, July 15th. KeyCorp reiterated a "buy" rating and set a $93.00 price target on shares of DuPont de Nemours in a research report on Thursday, September 16th. Finally, TheStreet upgraded shares of DuPont de Nemours from a "d+" rating to a "c" rating in a research report on Tuesday, August 3rd. Twelve equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $88.59. Read more …

 


Union Pacific (NYSE:UNP) was upgraded by investment analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research note issued on Monday, The Fly reports. The brokerage presently has a $260.00 price target on the railroad operator’s stock, up from their prior price target of $240.00. Barclays‘s price target indicates a potential upside of 28.88% from the company’s current price.

UNP has been the subject of a number of other reports. Evercore ISI restated a “buy” rating and issued a $228.00 target price on shares of Union Pacific in a research note on Friday, September 24th. Deutsche Bank Aktiengesellschaft lowered their price target on Union Pacific from $256.00 to $225.00 and set a “buy” rating on the stock in a research report on Friday, September 17th. Wells Fargo & Company upped their price target on Union Pacific from $226.00 to $231.00 and gave the company an “equal weight” rating in a research report on Friday, July 9th. Royal Bank of Canada upped their price target on Union Pacific from $259.00 to $261.00 and gave the company an “outperform” rating in a research report on Friday, July 23rd. Finally, Atlantic Securities assumed coverage on Union Pacific in a research report on Monday, July 12th. They issued an “overweight” rating and a $263.00 price target on the stock. Five equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Union Pacific presently has a consensus rating of “Buy” and an average target price of $243.82. Read more …

 


Freeport-McMoRan (NYSE:FCX) was upgraded by equities researchers at BNP Paribas from a "neutral" rating to an "outperform" rating in a report released on Wednesday, FinViz reports. The brokerage presently has a $39.50 price objective on the natural resource company's stock. BNP Paribas' price objective points to a potential upside of 22.67% from the stock's previous close.

Several other brokerages have also recently weighed in on FCX. Royal Bank of Canada lifted their price objective on shares of Freeport-McMoRan from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Friday, July 23rd. Bank of America assumed coverage on Freeport-McMoRan in a report on Wednesday, September 29th. They set a "buy" rating on the stock. Credit Suisse Group downgraded Freeport-McMoRan from a "neutral" rating to an "underperform" rating and set a $29.00 target price on the stock. in a research report on Friday, September 10th. Zacks Investment Research downgraded Freeport-McMoRan from a "hold" rating to a "sell" rating and set a $37.00 price target for the company. in a research note on Thursday, August 26th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Freeport-McMoRan from $47.00 to $46.00 and set a "buy" rating on the stock in a research note on Thursday, September 16th. Three analysts have rated the stock with a sell rating, four have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $38.37. Read more …

 

 


Phillips 66 (NYSE:PSX) was upgraded by Piper Sandler from a “neutral” rating to an “overweight” rating in a note issued to investors on Wednesday, FinViz reports. The brokerage presently has a $87.00 price target on the oil and gas company’s stock, up from their previous price target of $85.00. Piper Sandler’s price objective indicates a potential upside of 12.48% from the stock’s current price.

PSX has been the topic of several other research reports. decreased their price target on Phillips 66 from $126.00 to $95.00 and set a “buy” rating on the stock in a research note on Friday, July 9th. Morgan Stanley started coverage on Phillips 66 in a research report on Tuesday, September 7th. They set an “equal weight” rating and a $80.00 target price on the stock. cut their price objective on Phillips 66 from $126.00 to $95.00 and set a “buy” rating on the stock in a report on Friday, July 9th. Wells Fargo & Company lifted their price target on shares of Phillips 66 from $96.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, June 24th. Finally, Citigroup cut shares of Phillips 66 from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $95.00 to $75.00 in a report on Thursday, August 26th. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $84.31. Read more …